Paul A. Clarke
Institute of Cancer Research(GB)Cancer Research UK(GB)Oxford University Hospitals NHS Trust(GB)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Heat shock proteins research, Cancer-related Molecular Pathways, Chronic Lymphocytic Leukemia Research, Molecular Biology Techniques and Applications
Most-Cited Works
- → Patient-derived organoids model treatment response of metastatic gastrointestinal cancers(2018)1,968 cited
- → Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" Study(1998)741 cited
- → The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer(2008)741 cited
- → Discovery of small molecule cancer drugs: Successes, challenges and opportunities(2012)579 cited
- → Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1(2002)544 cited
- → BCL-2 antisense therapy in patients with non-Hodgkin lymphoma(1997)498 cited